Clinical Trial

The Effect of Cryocompression on Peripheral Neuropathy in Patients Receiving Chemotherapy for Gynecological Cancer

Study acronym: CryoPN
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2025 (before its estimated November 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study Design: This study is designed as a prospective, randomized controlled experimental study aiming to determine the effect of cryocompression therapy, applied during chemotherapy, on peripheral neuropathy symptoms in women with gynecologic cancers. Research Hypotheses: * H₀: Cryocompression therapy has no effect on peripheral neuropathy. * H₁: Cryocompression therapy has an effect on peripheral neuropathy. Study Population: The study population will consist of women over the age of 18 living in Mersin, Türkiye, who are diagnosed with gynecologic cancer and undergoing chemotherapy between August 10 and December 31, 2025.
Trial Details
NCT Number NCT07131618
Lead Sponsor Mersin University
Conditions Gynecological Cancers, Peripheral Neuropathy Due to Chemotherapy
Enrollment 78 participants
Start Date 2025-08-10
Primary Completion 2025-11-28 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-20